Purpose of the article: Placental accreta spectrum (PAS) is the most dangerous iatrogenic complication of cesarean potentially leading to massive intra-partum haemorrhage and death. Despite this, identification of near miss cases of PAS has not been consistently reported in the published literature. The aim of this systematic review was to explore prenatal and surgical characteristics of near miss cases of PAS disorders. Materials and methods: Medline, Embase, CINAHL, SciELO, and Cochrane databases were searched. Only studies including near miss cases of PAS disorders in which a detailed description of the clinical course, severity of placental invasion, role of prenatal imaging, and surgical management were considered eligible for the incl...
Recent population studies have shown that placenta accreta spectrum (PAS) disorders remain undiagnos...
Purpose of Review: Placenta accreta spectrum (PAS) is a rare pregnancy complication with an increasi...
Objective:Cesarean hysterectomy is generally presumed to decrease maternal morbidity and mortali...
OBJECTIVE: To report the occurrence of urologic complications in women undergoing surgery for placen...
Introduction: Incidence of placenta previa is 3-5per 1000 pregnancies. Placenta previa includes: i) ...
peer reviewedOBJECTIVES: Maternal mortality related to the placenta accreta spectrum (PAS) disorders...
Placenta accreta spectrum (PAS) is a major obstetrical problem whose incidence is rising. Current gu...
Introduction: The antenatal diagnosis of placenta accreta spectrum (PAS) is in large part subjective...
BACKGROUND: Placenta percreta is described as the most severe grade of placenta accreta spectrum (PA...
Objective To estimate the prevalence and incidence of placenta previa complicated by placenta accret...
INTRODUCTION: Management options for women with placenta accreta spectrum (PAS) comprise termination...
Objectives To elucidate the risk factor, histopathological correlations and diagnostic accuracy o...
Introduction Management options for women with placenta accreta spectrum (PAS) comprise termination ...
Placenta accreta spectrum encompasses a range of pathological adherence of placenta and causes signi...
Abstract. Posterior placenta accreta spectrum (PAS) disorders are infrequent but potentially associa...
Recent population studies have shown that placenta accreta spectrum (PAS) disorders remain undiagnos...
Purpose of Review: Placenta accreta spectrum (PAS) is a rare pregnancy complication with an increasi...
Objective:Cesarean hysterectomy is generally presumed to decrease maternal morbidity and mortali...
OBJECTIVE: To report the occurrence of urologic complications in women undergoing surgery for placen...
Introduction: Incidence of placenta previa is 3-5per 1000 pregnancies. Placenta previa includes: i) ...
peer reviewedOBJECTIVES: Maternal mortality related to the placenta accreta spectrum (PAS) disorders...
Placenta accreta spectrum (PAS) is a major obstetrical problem whose incidence is rising. Current gu...
Introduction: The antenatal diagnosis of placenta accreta spectrum (PAS) is in large part subjective...
BACKGROUND: Placenta percreta is described as the most severe grade of placenta accreta spectrum (PA...
Objective To estimate the prevalence and incidence of placenta previa complicated by placenta accret...
INTRODUCTION: Management options for women with placenta accreta spectrum (PAS) comprise termination...
Objectives To elucidate the risk factor, histopathological correlations and diagnostic accuracy o...
Introduction Management options for women with placenta accreta spectrum (PAS) comprise termination ...
Placenta accreta spectrum encompasses a range of pathological adherence of placenta and causes signi...
Abstract. Posterior placenta accreta spectrum (PAS) disorders are infrequent but potentially associa...
Recent population studies have shown that placenta accreta spectrum (PAS) disorders remain undiagnos...
Purpose of Review: Placenta accreta spectrum (PAS) is a rare pregnancy complication with an increasi...
Objective:Cesarean hysterectomy is generally presumed to decrease maternal morbidity and mortali...